Literature DB >> 12767927

Synleurin, a novel leucine-rich repeat protein that increases the intensity of pleiotropic cytokine responses.

Wei Wang1, Yan Yang, Lei Li, Yanggu Shi.   

Abstract

We have identified and characterized a novel single span transmembrane leucine-rich repeat protein, synleurin, that renders cells highly sensitive to the activation by cytokines and lipopolysaccharide (LPS). The major part of the extracellular domain consists of a leucine-rich repeats (LRR) cassette. The LRR central core has 12 analogous LRR repeating modules arranged in a seamless tandem array. The LRRs are most homologous to that of chondroadherin, insulin-like growth factor binding proteins, platelet glycoprotein V, slits, and toll-like receptors. Synleurin expression was detected at low levels in many tissues, including smooth muscle, brain, uterus, pancreas, cartilage, adipose, spleen, and testis. When synleurin is ecotopically expressed in transfected cells, the cells exhibit amplified responses to bFGF, EGF, PDGF-B, IGF-1, IGF-2, and LPS. Synleurin gene (slrn) maps to human chromosome at 5q12. The name synleurin reflects its synergistic effect on cytokine stimulation and its prominent leucine-rich repeats.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12767927     DOI: 10.1016/s0006-291x(03)00876-3

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  LRRC4 controls in vitro invasion of glioblastoma cells through inhibiting RPTP-zeta expression.

Authors:  Minghua Wu; Kai Gan; Chen Huang; Yunlian Tang; Qiong Chen; Ke Tang; Xiaoling Li; Shourong Shen; Guiyuan Li
Journal:  J Neurooncol       Date:  2006-08-29       Impact factor: 4.130

Review 2.  Bioinformatic description of immunotherapy targets for pediatric T-cell leukemia and the impact of normal gene sets used for comparison.

Authors:  Rimas J Orentas; Jessica Nordlund; Jianbin He; Sivasish Sindiri; Crystal Mackall; Terry J Fry; Javed Khan
Journal:  Front Oncol       Date:  2014-06-10       Impact factor: 6.244

Review 3.  Fundamental Characteristics of Bat Interferon Systems.

Authors:  Emily Clayton; Muhammad Munir
Journal:  Front Cell Infect Microbiol       Date:  2020-12-11       Impact factor: 5.293

4.  The extracellular leucine-rich repeat superfamily; a comparative survey and analysis of evolutionary relationships and expression patterns.

Authors:  Jackie Dolan; Karen Walshe; Samantha Alsbury; Karsten Hokamp; Sean O'Keeffe; Tatsuya Okafuji; Suzanne F C Miller; Guy Tear; Kevin J Mitchell
Journal:  BMC Genomics       Date:  2007-09-14       Impact factor: 3.969

5.  A novel fibroblast growth factor receptor family member promotes neuronal outgrowth and synaptic plasticity in aplysia.

Authors:  Daniela D Pollak; Bui Quang Minh; Ana Cicvaric; Francisco J Monje
Journal:  Amino Acids       Date:  2014-07-25       Impact factor: 3.520

6.  Six reference-quality genomes reveal evolution of bat adaptations.

Authors:  David Jebb; Zixia Huang; Martin Pippel; Graham M Hughes; Ksenia Lavrichenko; Paolo Devanna; Sylke Winkler; Lars S Jermiin; Emilia C Skirmuntt; Aris Katzourakis; Lucy Burkitt-Gray; David A Ray; Kevin A M Sullivan; Juliana G Roscito; Bogdan M Kirilenko; Liliana M Dávalos; Angelique P Corthals; Megan L Power; Gareth Jones; Roger D Ransome; Dina K N Dechmann; Andrea G Locatelli; Sébastien J Puechmaille; Olivier Fedrigo; Erich D Jarvis; Michael Hiller; Sonja C Vernes; Eugene W Myers; Emma C Teeling
Journal:  Nature       Date:  2020-07-22       Impact factor: 49.962

7.  Alterations of DNA methylation during adipogenesis differentiation of mesenchymal stem cells isolated from adipose tissue of patients with obesity is associated with type 2 diabetes.

Authors:  Elaheh Mirzaeicheshmeh; Carlos Zerrweck; Federico Centeno-Cruz; Paulina Baca-Peynado; Angélica Martinez-Hernandez; Humberto García-Ortiz; Cecilia Contreras-Cubas; María Guadalupe Salas-Martínez; Yolanda Saldaña-Alvarez; Elvia C Mendoza-Caamal; Francisco Barajas-Olmos; Lorena Orozco
Journal:  Adipocyte       Date:  2021-12       Impact factor: 4.534

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.